| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Eledon Pharmaceuticals, Inc. (ELDN) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 1 sell. ELDN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 3.4K | $13.3K | - | |
| Dir | 3.4K | $13.3K | - | |
| Dir | 3.4K | $13.3K | - | |
| Dir | 3.4K | $13.3K | - | |
| Dir | 3.4K | $13.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 2, 2015 | Kalowski Lee62 | Chief Financial Officer | Sell | 2,258 | $11.45 | $25,854.10 | -4.1% |